Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data

Maybe it's time to return the favor
Peptiology cannot verify reconstitution compatibility where non-Peptiology diluents have been used
The magnitude of this effect varies with GH pulse amplitude and duration again favoring robust pulsatile protocols (CJC-1295/ipamorelin) over gentle stimulation (sermorelin alone)
Here are the Foxtale serums worth knowing about, what each one does, and how to figure out which one your skin needs
Legal Status: BPC157 vs MK677 vs CJC1295 vs TB500 Each of these peptides occupies a unique legal category , depending on the country, the intent of use (research vs human consumption), and whether the compound has been classified by regulatory agencies like the FDA , DEA , or WADA